President Trump signed an executive order on October 19, 2026, directing the creation of a dedicated women’s health division within the National Institutes of Health, plus a new White House task force focused on women’s health. First Lady Melania Trump spearheaded the initiative, calling it a transformative moment for women’s health in America.
Here’s what the order actually directs, who’s running it, and what it doesn’t promise yet.
What the order creates
The order requires HHS to establish the new NIH division within 90 days. According to the White House, it won’t replace the agency’s existing Office of Research on Women’s Health, but is meant to carry a broader mandate: accelerating scientific discoveries, expanding clinical access to women’s health care, and modernizing treatment at every stage of a woman’s life.
The companion task force is co-chaired by White House Chief of Staff Susie Wiles and Health and Human Services Secretary Robert F. Kennedy Jr.
What the five pillars actually name
The First Lady’s office has described five pillars for the initiative, though only two have been detailed publicly so far: funding targeted research toward cures for diseases that specifically affect women, such as endometriosis, and speeding the timeline for promising therapeutics to reach female patients.
Notably absent from what’s been made public: menopause and heart disease aren’t named as priority areas in the order itself, even though both are common concerns an initiative like this one gets compared to.
What it doesn’t do
An executive order sets direction and requires agencies to act within a timeline, but it isn’t a budget. The order directs HHS to fund the task force’s own administrative costs, with no specific research-funding target or dollar figure attached. That matters here in particular: NIH has absorbed thousands of layoffs, was directed to cut spending by roughly 35 percent, and is facing a 2.6 billion dollar budget reduction, the backdrop this new division will have to operate against.
The bottom line
A new NIH division and a White House task force are real, with a 90-day clock and two named co-chairs. What isn’t yet real: a budget, a leadership team for the division itself, or confirmation that menopause and cardiovascular research specifically will fall under its mandate. Those details are what will determine whether this becomes a meaningful shift in women’s health research funding, or stays mostly symbolic.